Morgan Stanley on Emerson's (EMR) NI (NATI) Deal: Higher Purchase Price than Expected but Solid Margin Walk
Tweet Send to a Friend
Morgan Stanley analyst Joshua Pokrzywinski reiterated an Overweight rating and $96.00 price target on Emerson (NYSE: EMR)."EMR's $60 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
